APA (7th ed.) Citation

Hoekstra, R., de Vos, F. Y., Eskens, F. A., Gietema, J. A., van der Gaast, A., Groen, H. J., . . . de Vries, E. G. (2005). Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer. Journal of clinical oncology, 23(22), 5188-5197. https://doi.org/10.1200/JCO.2005.05.013

Chicago Style (17th ed.) Citation

Hoekstra, Ronald, et al. "Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer." Journal of Clinical Oncology 23, no. 22 (2005): 5188-5197. https://doi.org/10.1200/JCO.2005.05.013.

MLA (9th ed.) Citation

Hoekstra, Ronald, et al. "Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer." Journal of Clinical Oncology, vol. 23, no. 22, 2005, pp. 5188-5197, https://doi.org/10.1200/JCO.2005.05.013.